|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Moderna (NASDAQ: MRNA) through any online brokerage.
The latest price target for Moderna (NASDAQ: MRNA) was reported by Chardan Capital on May 7, 2021. The analyst firm set a price target for 188.00 expecting MRNA to fall to within 12 months (a possible -5.62% downside). 34 analyst firms have reported ratings in the last year.
The stock price for Moderna (NASDAQ: MRNA) is $199.19 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Moderna.
There is no upcoming split for Moderna.
Moderna is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.